Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant
Angela R. Seasely, Christina T. Blanchard, Nitin Arora, Ashley N. Battarbee, Brian M. Casey, Jodie Dionne-Odom, Sixto M. Leal, Derek B. Moates, Rachel G. Sinkey, Jeff M. Szychowski, Alan T. Tita, Akila Subramaniam, on behalf of the CWRH COVID-19 Working Group
Abstract
In Brief Our findings suggest increased critical illness and adverse perinatal outcomes associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant in pregnancy.
Topics & Concepts
MedicineCoronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)PandemicAcute diarrhea2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirusDeltaRespiratory illnessRespiratory systemBetacoronavirusCoronavirus InfectionsPediatricsVirologySeverity of illnessCritical illnessIntensive care medicinePregnancyIntensive careInternal medicineRespiratory diseasePneumoniaSevere acute respiratory syndromeCritically illMEDLINEMaternal morbidityIntensive care unitImmunologyCOVID-19 Impact on ReproductionCOVID-19 and healthcare impactsMaternal and fetal healthcare